Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03427931 · ClinicalTrials.gov registry record · NA
CGM Use in Islet Transplant Recipients
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 7
- Enrollment target
NCT03427931 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 7 participants.
The verdict
NCT03427931, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 7 participants
- Enrollment target
Study Summary
A study assessing glucose variability in subjects with Type 1 Diabetes who have had islet transplant.
Interventions
- OTHER Continuous Glucose Monitor (CGM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2018-02-01 |
| Est. Completion | 2019-07-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03427931
The ClinicalTrials.gov registry entry for NCT03427931 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Continuous Glucose Monitor (CGM) is the first listed.
NCT03427931 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03427931 about?
NCT03427931 is a clinical study titled "CGM Use in Islet Transplant Recipients". A study assessing glucose variability in subjects with Type 1 Diabetes who have had islet transplant.
What is the current status of trial NCT03427931?
This trial is currently completed. It is a NA study. The enrollment target is 7 participants. The study started on 2018-02-01. Estimated completion is 2019-07-11.
What interventions are being tested in trial NCT03427931?
The interventions under investigation include: Continuous Glucose Monitor (CGM) (OTHER).
Who is sponsoring clinical trial NCT03427931?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.